Cytochrome P450 Drug Interactions for MRCP Part 1
- Crack Medicine

- Jun 1
- 3 min read
TL;DR
For MRCP Part 1, mastering Cytochrome P450 drug interactions MRCP Part 1 is essential for scoring pharmacology questions. Focus on high-yield inhibitors and inducers—especially CYP3A4—and recognise classic clinical patterns like warfarin toxicity and statin-induced rhabdomyolysis. Learn patterns, not isolated facts. Reinforce with MCQs and recall-based revision.
Why this matters
Cytochrome P450 (CYP450) drug interactions are one of the most consistently tested pharmacology topics in MRCP Part 1. They connect basic pharmacology to real clinical scenarios—anticoagulation, epilepsy, infections, and cardiology.
The exam rarely tests obscure mechanisms. Instead, it focuses on:
Recognising drug combinations
Predicting clinical consequences
Distinguishing enzyme inhibition vs induction
A structured approach using the MRCP Part 1 overview ensures you integrate pharmacology with clinical systems.
Core sections
1. The CYP450 system: What you must know
Located mainly in the liver (smooth endoplasmic reticulum)
Responsible for Phase I drug metabolism (oxidation)
Key isoenzymes:
CYP3A4 → most clinically relevant
CYP2D6 → genetic polymorphism
CYP2C9 → warfarin metabolism
CYP1A2 → affected by smoking
👉 Exam focus: clinical effects, not enzyme biochemistry.
2. High-yield CYP inhibitors (Mnemonic: SICKFACES.COM)
Category | Examples | Clinical relevance |
Sodium valproate | Antiepileptic | ↑ lamotrigine levels |
Isoniazid | Anti-TB | ↑ phenytoin toxicity |
Cimetidine | H2 blocker | Multiple interactions |
Ketoconazole | Antifungal | Strong CYP3A4 inhibition |
Fluconazole | Antifungal | ↑ warfarin INR |
Alcohol (acute) | ↓ metabolism | |
Chloramphenicol | Antibiotic | ↑ toxicity |
Erythromycin/Clarithromycin | Macrolides | ↑ statin toxicity |
Sulfonamides | ↑ bleeding risk | |
Ciprofloxacin | ↑ theophylline | |
Omeprazole | CYP2C19 inhibition |
👉 Pattern: Inhibitors → ↑ drug levels → toxicity
3. High-yield CYP inducers
Category | Examples | Clinical relevance |
Rifampicin | Anti-TB | ↓ OCP efficacy |
Carbamazepine | Antiepileptic | ↓ warfarin effect |
Phenytoin | Antiepileptic | Auto-induction |
Phenobarbital | Broad induction | |
St John’s Wort | Herbal | ↓ many drugs |
Chronic alcohol | Enzyme induction | |
Griseofulvin | Antifungal | ↓ contraceptive effect |
👉 Pattern: Inducers → ↓ drug levels → treatment failure
4. The 5 most tested subtopics
1. Warfarin interactions
Metabolised by CYP2C9
Inhibitors → ↑ INR → bleeding
Inducers → ↓ INR → thrombosis
2. Statin toxicity
Simvastatin metabolised by CYP3A4
Macrolides/azoles → ↑ rhabdomyolysis risk
3. Oral contraceptive failure
Rifampicin induces metabolism → ↓ efficacy
4. Antiepileptic drug interactions
Phenytoin: inducer + substrate
Complex and frequently tested
5. Theophylline toxicity
Narrow therapeutic index
Ciprofloxacin ↑ levels → arrhythmias
5. Isoenzyme-specific associations
CYP3A4
Drugs: statins, ciclosporin, calcium channel blockers
Inhibitors: macrolides, azoles, grapefruit juice
CYP2D6
Codeine activation → morphine
Poor metabolisers → reduced effect
CYP2C9
Warfarin metabolism
Inhibition → bleeding
6. Clinical patterns you must recognise
Bleeding → warfarin + inhibitor
Muscle pain → statin + macrolide
Pregnancy → OCP + rifampicin
Seizure recurrence → antiepileptic + inducer
Toxicity → narrow therapeutic drugs
7. Study strategy (High-yield checklist)
Memorise SICKFACES.COM
Recall rifampicin as a strong inducer
Focus on warfarin interactions
Revise statin complications
Identify narrow therapeutic drugs
Practise recognition-based MCQs
Use spaced repetition
Reinforce your knowledge using Free MRCP MCQs and simulate exam pressure with Start a mock test.

Practical examples / mini-cases
MCQ Example
A 70-year-old woman on simvastatin is prescribed clarithromycin for pneumonia. She develops muscle pain and dark urine.
What is the most likely diagnosis?
A. Acute kidney injuryB. RhabdomyolysisC. HepatitisD. MyositisE. Drug allergy
Answer: B. Rhabdomyolysis
Explanation: Clarithromycin inhibits CYP3A4 → ↑ simvastatin levels → muscle breakdown → rhabdomyolysis. A classic MRCP Part 1 drug interaction scenario.
Common pitfalls (5 bullets)
Confusing inhibitors with inducers
Ignoring herbal medications (St John’s Wort)
Forgetting acute vs chronic alcohol effects
Missing statin–macrolide interaction
Failing to identify clinical consequences
FAQs
1. Which CYP enzyme is most important for MRCP Part 1?
CYP3A4 is the most important as it metabolises a large number of drugs and is frequently involved in interactions.
2. What is the easiest way to remember CYP inhibitors?
Use the mnemonic SICKFACES.COM, which covers most high-yield inhibitors tested in MRCP exams.
3. Why is warfarin commonly tested?
Because it has a narrow therapeutic index and is highly sensitive to CYP2C9 interactions.
4. Do I need to memorise all CYP enzymes?
No—focus on CYP3A4, CYP2D6, and CYP2C9 along with key drug examples.
5. How are CYP interactions tested in MRCP Part 1?
Through clinical scenarios involving toxicity, treatment failure, or unexpected drug effects.
Ready to start?
Build confidence in pharmacology by integrating CYP450 revision into your daily study plan. Start with the MRCP Part 1 overview, practise with Free MRCP MCQs, and test yourself under real conditions using Start a mock test.
For deeper understanding, link this topic with broader pharmacology revision and clinical case practice.
Sources
MRCP(UK) Syllabus: https://www.mrcpuk.org/mrcpuk-examinations
British National Formulary (BNF): https://bnf.nice.org.uk/
NICE Clinical Knowledge Summaries: https://cks.nice.org.uk/
Rang & Dale’s Pharmacology (9th Edition)



Comments